MedPath

Biocomp Pharma, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

20

FDA:20

Drug Approvals

SODIUM SULFACETAMIDE

Approval Date
Mar 6, 2024
FDA

UREA

Approval Date
Mar 6, 2024
FDA

Urea 39% Cream

Approval Date
Mar 6, 2024
FDA

SODIUM SULFACETAMIDE AND SULFUR

Approval Date
Mar 6, 2024
FDA

Carbinoxamine Maleate

Approval Date
Mar 6, 2024
FDA

Potassium Citrate

Approval Date
Feb 27, 2024
FDA

Gabapentin

Approval Date
Nov 30, 2023
FDA

Sodium Sulfacetamide, Sulfur

Approval Date
Nov 7, 2023
FDA

SULFACETAMIDE SODIUM, SULFUR

Approval Date
Nov 7, 2023
FDA

SULFACETAMIDE SODIUM

Approval Date
Aug 28, 2023
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.